Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

1 results
3:22 PM, Jan 26, 2017  |  BC Innovations | Strategy

Deep roots

In a New England Journal of Medicine study published last March, the partners showed inactivating ANGPTL4
from the Geisinger cohort were associated with decreased triglyceride levels and risk of CAD. An anti-ANGPTL4
Euronext:SAN; NYSE:SNY), Paris, France Vanderbilt University, Nashville, Tenn. Targets and Compounds  ANGPTL3 - Angiopoietin-like 3 ANGPTL4